Multiple Myeloma Therapeutics Market Size, Share & Trends Report

Multiple Myeloma Therapeutics Market Size, Share & Trends Analysis Report By Drug, By Disease (Active Multiple Myeloma, Smoldering Multiple Myeloma), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68039-913-1
Number of Report Pages: 80
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Multiple Myeloma Therapeutics Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Multiple Myeloma Therapeutics Market Analysis Tools
  3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Multiple Myeloma Therapeutics Market: Drug Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Multiple Myeloma Therapeutics Market: Drug Movement Analysis, 2023 & 2030 (USD Million)
  4.3. Chemotherapy and Other Drugs
  4.3.1. Chemotherapy and Other Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.2. Traditional Chemotherapy
  4.3.2.1. Traditional Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.3. Immunomodulating Agents
  4.3.3.1. Immunomodulating Agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.4. Proteasome Inhibitors
  4.3.4.1. Proteasome Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.5. Histone Deacetylase (HDAC) Inhibitors
  4.3.5.1. Histone Deacetylase (HDAC) Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.6. Monoclonal Antibodies
  4.3.6.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4. Radiation
  4.4.1. Radiation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5. Stem Cell Transplant and Supportive Treatment
  4.5.1. Stem Cell Transplant and Supportive Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Multiple Myeloma Therapeutics Market: Disease Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Multiple Myeloma Therapeutics Market: Disease Movement Analysis, 2023 & 2030 (USD Million)
  5.3. Active Multiple Myeloma
  5.3.1. Active Multiple Myeloma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.4. Smoldering Multiple Myeloma
  5.4.1. Smoldering Multiple Myeloma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Multiple Myeloma Therapeutics Market: End Use Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Multiple Myeloma Therapeutics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  6.3. Hospitals
  6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4. Clinics
  6.4.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5. Other
  6.5.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Multiple Myeloma Therapeutics Market: Regional Estimates & Trend Analysis
  7.1. Multiple Myeloma Therapeutics Market Share, By Region, 2023 & 2030 (USD Million)
  7.2. North America
  7.2.1. North America Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.2. U.S.
  7.2.2.1. U.S. Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.3. Canada
  7.2.3.1. Canada Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.4. Mexico
  7.2.4.1. Mexico Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3. Europe
  7.3.1. Europe Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.2. UK.
  7.3.2.1. UK Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.3. Germany
  7.3.3.1. Germany Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.4. France
  7.3.4.1. France Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.5. Italy
  7.3.5.1. Italy Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.6. Spain
  7.3.6.1. Spain Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.7. Denmark
  7.3.7.1. Denmark Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.8. Sweden
  7.3.8.1. Sweden Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.9. Norway
  7.3.9.1. Norway Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4. Asia Pacific
  7.4.1. Asia Pacific Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.2. Japan
  7.4.2.1. Japan Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.3. China
  7.4.3.1. China Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.4. India
  7.4.4.1. India Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.5. Australia
  7.4.5.1. Australia Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.6. South Korea
  7.4.6.1. South Korea Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.7. Thailand
  7.4.7.1. Thailand Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5. Latin America
  7.5.1. Latin America Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.2. Brazil
  7.5.2.1. Brazil Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.3. Argentina
  7.5.3.1. Argentina Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6. Middle East and Africa
  7.6.1. Middle East and Africa Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.2. South Africa
  7.6.2.1. South Africa Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.3. Saudi Arabia
  7.6.3.1. Saudi Arabia Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.4. UAE
  7.6.4.1. UAE Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.5. Kuwait
  7.6.5.1. Kuwait Multiple Myeloma Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
  8.1. Recent Developments & Impact Analysis by Key Market Participants
  8.2. Company Categorization
  8.3. Company Heat Map Analysis
  8.4. Company Profiles
  8.4.1. Johnson & Johnson Services, Inc.
  8.4.1.1. Participant’s Overview
  8.4.1.2. Financial Performance
  8.4.1.3. Product Benchmarking
  8.4.1.4. Recent Developments/ Strategic Initiatives
  8.4.2. Novartis AG
  8.4.2.1. Participant’s Overview
  8.4.2.2. Financial Performance
  8.4.2.3. Product Benchmarking
  8.4.2.4. Recent Developments/ Strategic Initiatives
  8.4.3. Amgen Inc.
  8.4.3.1. Participant’s Overview
  8.4.3.2. Financial Performance
  8.4.3.3. Product Benchmarking
  8.4.3.4. Recent Developments/ Strategic Initiatives
  8.4.4. Sanofi
  8.4.4.1. Participant’s Overview
  8.4.4.2. Financial Performance
  8.4.4.3. Product Benchmarking
  8.4.4.4. Recent Developments/ Strategic Initiatives
  8.4.5. Bristol-Myers Squibb Company.
  8.4.5.1. Participant’s Overview
  8.4.5.2. Financial Performance
  8.4.5.3. Product Benchmarking
  8.4.5.4. Recent Developments/ Strategic Initiatives
  8.4.6. Takeda Pharmaceutical Company Limited.
  8.4.6.1. Participant’s Overview
  8.4.6.2. Financial Performance
  8.4.6.3. Product Benchmarking
  8.4.6.4. Recent Developments/ Strategic Initiatives
  8.4.7. Merck & Co.
  8.4.7.1. Participant’s Overview
  8.4.7.2. Financial Performance
  8.4.7.3. Product Benchmarking
  8.4.7.4. Recent Developments/ Strategic Initiatives
  8.4.8. AbbVie Inc.
  8.4.8.1. Participant’s Overview
  8.4.8.2. Financial Performance
  8.4.8.3. Product Benchmarking
  8.4.8.4. Recent Developments/ Strategic Initiatives
  8.4.9. GLENMARK PHARMACEUTICALS LTD.
  8.4.9.1. Participant’s Overview
  8.4.9.2. Financial Performance
  8.4.9.3. Product Benchmarking
  8.4.9.4. Recent Developments/ Strategic Initiatives
  8.4.10. DAIICHI SANKYO COMPANY, LIMITED
  8.4.10.1. Participant’s Overview
  8.4.10.2. Financial Performance
  8.4.10.3. Product Benchmarking
  8.4.10.4. Recent Developments/ Strategic Initiatives
  8.4.11. bluebird bio, Inc.
  8.4.11.1. Participant’s Overview
  8.4.11.2. Financial Performance
  8.4.11.3. Product Benchmarking
  8.4.11.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.